#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma gastric Sickle cell anaemia Marginal zone lymphoma refractory Oropharyngeal squamous cell carcinoma Deafness Neovascular age-related macular degeneration KBG syndrome Familial hypertriglyceridaemia Cardiomyopathy Pneumonia Marginal zone lymphoma Infertility female Cluster headache Solitary fibrous tumour Pyoderma gangrenosum More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Basic Information Castleman’s disease – Life with Disease Pleomorphic leiomyosarcoma – Treatment Myelodysplastic syndrome – Trials in Disease Haemophilia B with anti factor IX – Trials in Disease Usher’s syndrome Medulloblastoma recurrent – Basic Information Pleural mesothelioma malignant – Basic Information Angiosarcoma – Diagnostics X-linked lymphoproliferative syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VOXVOGANAN A49 Progesterone, Micronised Fluoxetine Db-Oto-3 1,3-BUTYLENE GLYCOL Crn04894 Sonidegib Deferoxamine Fremanezumab Monalizumab Ciclosporin A L-PHENYLALANINE Air, Medicinal Codeine Phosphate Hemihydrate Cefazolin Oxytocin Synthetic GLYCYL-TYROSINE Cipaglucosidase Alfa Pamidronate Disodium More therapies…

    Learn about Your Condition

    Athetosis Thyroidectomy Retinoblastoma Vestibular disorder Dementia Acute leukaemia Tympanic membrane perforation Atopic keratoconjunctivitis Small intestine carcinoma Brain stem glioma Toxic nodular goitre Anal cancer stage II Metabolic disorder Suicidal ideation Kaposi's sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary fibrosis
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bi 1839100
    Austria Belgium Czechia Denmark Finland France +9

  • Study on the Safety and Effects of Sebetralstat for Children Aged 2-11 with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • Sebetralstat
    France Germany Italy

  • Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bi 1819479
    Austria Belgium Czechia Denmark Finland France +8

  • Study on Rituximab, Bendamustine, Cytarabine, and Venetoclax for High-Risk Elderly Patients with Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cytarabine
    • Rituximab
    Italy

  • Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • Amlitelimab
    Belgium Czechia Finland France Germany Greece +6

  • Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

    Not recruiting

    2 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    Investigated Drugs:
    • (S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt
    France Germany Hungary Italy Poland Portugal +1

  • Study on Vedolizumab for Patients with Active Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Belgium France Italy The Netherlands Poland

  • Study of Clenbuterol vs Placebo in Adult Patients with Spinal and Bulbar Muscular Atrophy (SBMA)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bulbospinal muscular atrophy congenital
    • Spinal muscular atrophy
    Investigated Drugs:
    • Clenbuterol Hydrochloride
    Italy

  • Study on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Imlifidase
    Austria Belgium Czechia France Germany Italy +4

  • Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Eplontersen
    Austria Belgium Czechia Denmark France Germany +6
Previous Page
1 … 26 27 28 29 30 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!